Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Indorama Ventures PCLINDOY 72 Equity-to-Asset is 0.23 as of Mar. 2026, which is 23% below its 10-year median of 0.30. GuruFocus rates INDOY with a GF Score™ of 72/100 and a GF Value™ of $5.66. The stock has 9 warning signs investors should review. Among 1,612 Chemicals companies, Indorama Ventures PCL ranks worse than 92.93% on this metric.
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Indorama Ventures PCL Equity-to-Asset Related Terms
Indorama Ventures PCL Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Indorama Ventures PCL's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Chemicals subindustry, Indorama Ventures PCL's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Indorama Ventures PCL Equity-to-Asset vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Indorama Ventures PCL's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Indorama Ventures PCL's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Indorama Ventures PCL's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Indorama Ventures PCL (INDOY) has a Equity-to-Asset of 0.23 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Indorama Ventures PCL and its competitors. This is 23% below median its historical median of 0.30. Over the past decade, Indorama Ventures PCL's Equity-to-Asset has ranged from 0.23 to 0.44. According to the industry distribution chart, Indorama Ventures PCL ranks #1498 out of 1612 companies in the Chemicals industry, placing it in the top 92.9%.
Is Indorama Ventures PCL's Equity-to-Asset too high?
Indorama Ventures PCL's current Equity-to-Asset of 0.23 is 23% below median its 10-year median of 0.30. Over the past 10 years, this metric has ranged from a low of 0.23 to a high of 0.44. The Chemicals industry median Equity-to-Asset is 0.60. Indorama Ventures PCL's value of 0.23 is 61.7% below this industry median. Based on the distribution chart, Indorama Ventures PCL ranks #1498 out of 1612 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Indorama Ventures PCL has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Indorama Ventures PCL's Equity-to-Asset compare to DOW?
According to the Chemicals industry distribution chart, Indorama Ventures PCL ranks #1498 out of 1612 companies for Equity-to-Asset. This places Indorama Ventures PCL in the lower half of its industry. The industry median Equity-to-Asset is 0.60. Indorama Ventures PCL's value of 0.23 is 61.7% below this benchmark. Historically, Indorama Ventures PCL's own Equity-to-Asset has ranged from 0.23 to 0.44 over the past decade. While the company's 10-year median is 0.30 vs. the industry median of 0.60, Indorama Ventures PCL has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Chemicals company?
The median Equity-to-Asset among Chemicals companies is 0.60, based on 1,612 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Indorama Ventures PCL's current Equity-to-Asset of 0.23 is 61.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Indorama Ventures PCL and its competitors. For the Chemicals industry, the median Equity-to-Asset is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Indorama Ventures PCL's current Equity-to-Asset is 0.23, which is 23% below median its own 10-year median of 0.30. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Indorama Ventures PCL stock overvalued right now?
Indorama Ventures PCL (INDOY) has a current Equity-to-Asset of 0.23. The stock's GF Value™ is $5.66, compared to a current price of $7.03 — trading 24.2% above its estimated fair value. The current Equity-to-Asset is 0.23, which is 23% below median its 10-year median of 0.30 and 61.7% below the Chemicals industry median of 0.60. Indorama Ventures PCL's overall GF Score™ is 72/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Indorama Ventures PCL (INDOY), the current Equity-to-Asset is 0.23 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Indorama Ventures PCL (INDOY) Overvalued in 2026?
Based on GuruFocus' analysis, Indorama Ventures PCL stock appears to be overvalued.
The current stock price of $7.03 is trading 24.2% above its estimated GF Value™ of $5.66.
Key valuation signals for INDOY:
Equity-to-Asset: 0.23 (23% below median its 10-year median of 0.30)
GF Value™: $5.66 vs. price of $7.03 (24.2% above fair value)
Industry Position: 61.7% below the Chemicals median (#1498 of 1612)
No single metric tells the full story. See the INDOY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Indorama Ventures PCL is engaged in the manufacture and distribution of Polyethylene Terephthalate, Purified Terephthalic Acid, Paraxylene, recycling, Purified Isophthalic Acid, Naphthalene Dicarboxylate, PET preforms and packaging, Integrated EG, Integrated purified EO, PO/MTBE, Integrated Surfactants comprising EOA, LAB and others, Fibers including Polyester, Rayon, Nylon, Polypropylene, composites and worsted wool fibers products. The company operates in three reportable segments Combined PET, Integrated Oxides and Derivatives and Fibers. The maximum revenue is derived from the Combined PET segment.
72GF Score
Get the complete analysis for INDOY
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
INDOY has been successfully added to your 
